Medicare AdvantageApril 18, 2025
Specialty pharmacy preapproval list update
Effective for dates of service on and after August 1, 2025, the specialty Medicare Part B drug listed in the table below will be included in our preapproval review process.
Federal and state law, state contract language, and CMS guidelines, including definitions and specific contract provisions/exclusions, take precedence over preapproval rules and must be considered first when determining coverage. Claims that do not comply with these new requirements may not be approved.
HCPCS code | Medicare Part B drug |
Q5136 | Jubbonti; Wyost (denosumab‑bbdz) |
Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
MULTI-BCBS-CR-077559-25-CPN77132
PUBLICATIONS: May 2025 Provider Newsletter
To view this article online:
Visit https://providernews.anthem.com/nevada/articles/specialty-pharmacy-preapproval-list-update-24890
Or scan this QR code with your phone